Figure 4: One-way analysis of anti-glycan autoantibodies between the PCa group (N=17) and the BPH group (N=12). Autoantibody reactivity with N-glycan cryptic antigen, AGOR (A), ASOR (B), and Man9 clusters (C and D) are generally present but are selectively enhanced to target the Man9-cluster epitopes in sera from prostate cancer patients (C and D).